1. Home
  2. NLSP vs LTRY Comparison

NLSP vs LTRY Comparison

Compare NLSP & LTRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • LTRY
  • Stock Information
  • Founded
  • NLSP 2015
  • LTRY 2015
  • Country
  • NLSP Switzerland
  • LTRY United States
  • Employees
  • NLSP N/A
  • LTRY N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • LTRY Computer Software: Prepackaged Software
  • Sector
  • NLSP Health Care
  • LTRY Technology
  • Exchange
  • NLSP Nasdaq
  • LTRY Nasdaq
  • Market Cap
  • NLSP 8.2M
  • LTRY 8.8M
  • IPO Year
  • NLSP 2021
  • LTRY N/A
  • Fundamental
  • Price
  • NLSP $0.19
  • LTRY $1.82
  • Analyst Decision
  • NLSP Hold
  • LTRY
  • Analyst Count
  • NLSP 1
  • LTRY 0
  • Target Price
  • NLSP N/A
  • LTRY N/A
  • AVG Volume (30 Days)
  • NLSP 11.0M
  • LTRY 321.4K
  • Earning Date
  • NLSP 07-30-2024
  • LTRY 08-20-2024
  • Dividend Yield
  • NLSP N/A
  • LTRY N/A
  • EPS Growth
  • NLSP N/A
  • LTRY N/A
  • EPS
  • NLSP N/A
  • LTRY N/A
  • Revenue
  • NLSP N/A
  • LTRY $6,626,564.00
  • Revenue This Year
  • NLSP N/A
  • LTRY N/A
  • Revenue Next Year
  • NLSP N/A
  • LTRY N/A
  • P/E Ratio
  • NLSP N/A
  • LTRY N/A
  • Revenue Growth
  • NLSP N/A
  • LTRY 75.84
  • 52 Week Low
  • NLSP $0.11
  • LTRY $0.82
  • 52 Week High
  • NLSP $1.21
  • LTRY $13.00
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 49.01
  • LTRY 72.08
  • Support Level
  • NLSP $0.19
  • LTRY $0.92
  • Resistance Level
  • NLSP $0.24
  • LTRY $2.20
  • Average True Range (ATR)
  • NLSP 0.03
  • LTRY 0.27
  • MACD
  • NLSP -0.00
  • LTRY 0.12
  • Stochastic Oscillator
  • NLSP 15.85
  • LTRY 72.40

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About LTRY Lottery.com Inc.

Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.

Share on Social Networks: